Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured on the AGE1.CR.pIX Avian Cell Line

Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured on the AGE1.CR.pIX Avian Cell Line

Seasonal influenza infections have a significant global impact leading to increased health and economic burden. The efficacy of currently available seasonal influenza vaccines targeting polymorphic surface antigens has historically been suboptimal. Cellular immune responses against highly conserved...

Full description

Bibliographic Details
Main Authors: Pedro M. Folegatti, Duncan Bellamy, Amy Flaxman, Catherine Mair, Chris Ellis, Raquel L. Ramon, Fernando Ramos Lopez, Celia Mitton, Megan Baker, Ian Poulton, Alison Lawrie, Rachel Roberts, Angela Minassian, Katie J. Ewer, Thomas G. Evans, Adrian V. S. Hill, Sarah C. Gilbert
Format: Article
Language:English
Published: MDPI AG 2019-03-01
Series:Vaccines
Subjects:
influenza
heterosubtypic vaccine
safety
immunogenicity
viral vectors
Online Access:https://www.mdpi.com/2076-393X/7/1/33

Internet

https://www.mdpi.com/2076-393X/7/1/33

Similar Items